Anti-PDE3A antibody [EPR28228-6] - BSA and Azide free
- Recombinant
- RabMAb
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal PDE3A antibody. Carrier free. Suitable for WB and reacts with Transfected cell lysate - Human, Human samples.
View Alternative Names
Cyclic GMP-inhibited phosphodiesterase A, cGMP-inhibited cAMP phosphodiesterase, CGI-PDE A, cGI-PDE, PDE3A
- WB
Supplier Data
Western blot - Anti-PDE3A antibody [EPR28228-6] - BSA and Azide free (AB315280)
This data was developed using ab315279, the same antibody clone in a different buffer formulation.
Low expression : HEK-293 (PMID : 17124499), HuT-78 (PMID : 32005668).
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 17124499).
The identity of the lower MW band at approximately 18 kDa is unknown.
This blot of lane 4 was developed using a high sensitivity ECL substrate.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
Exposure time : Lanes 1-3 : 114 seconds; Lane 4 : 81 seconds.
All lanes:
Western blot - Anti-PDE3A antibody [EPR28228-6] (<a href='/en-us/products/primary-antibodies/pde3a-antibody-epr28228-6-ab315279'>ab315279</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HEK-293 (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 3:
HuT-78 (human sezary syndrome cutaneous t lymphocyte) whole cell lysate at 20 µg
Lane 4:
SH-SY5Y (human neuroblastoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 125 kDa,90 kDa,70 kDa,36 kDa
false
- WB
Supplier Data
Western blot - Anti-PDE3A antibody [EPR28228-6] - BSA and Azide free (AB315280)
This data was developed using ab315279, the same antibody clone in a different buffer formulation.
This antibody does not cross-react with human PDE3B.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) staining at 1/5000 dilution.
All lanes:
Western blot - Anti-PDE3A antibody [EPR28228-6] (<a href='/en-us/products/primary-antibodies/pde3a-antibody-epr28228-6-ab315279'>ab315279</a>) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) cells transfected with an empty vector containing a myc-His-tag®, whole cell lysate at 7 µg
Lane 2:
293T cells transfected with a human PDE3A expression vector containing a myc-His-tag®, whole cell lysate at 7 µg
Lane 3:
293T cells transfected with a human PDE3B expression vector containing a myc-His-tag®, whole cell lysate at 7 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 125 kDa,90 kDa,70 kDa,36 kDa
false
Exposure time: 6s
Related conjugates and formulations (1)
-
Anti-PDE3A antibody [EPR28228-6]
Reactivity data
Product details
ab315280 is the carrier-free version of ab315279.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Phosphodiesterase 3A plays an important role in cardiac and vascular functions. It forms part of a signaling complex responsible for regulating cardiovascular responses. PDE3A manages intracellular cAMP and cGMP concentrations impacting vascular smooth muscle relaxation and platelet aggregation. The modulation of these signaling molecules by PDE3A contributes to maintaining normal heart rhythms and influencing blood pressure.
Pathways
Phosphodiesterase 3A is central to the cAMP and cGMP signaling pathways. PDE3A activity connects to the cardiac contractility pathway where it works alongside proteins like protein kinase A (PKA) which depends on cAMP levels. In the vascular system PDE3A activity is interlinked with the nitric oxide (NO) pathway where it modulates the effects of cGMP-dependent protein kinase (PKG). Together they orchestrate vascular actions such as smooth muscle contraction and vasodilation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com